Background and Purpose-Radiological findings play an essential role in therapeutic decision making and prognostication in acute ischemic stroke (AIS). The Boston Acute Stroke Imaging Scale (BASIS) and Middle Cerebral Artery-BASIS (M1-BASIS) methodologies are rapid purely radiological instruments and easily applicable for patients with AIS. We validated these methods in patients with AIS treated with intravenous tissue-type plasminogen activator. Methods-For BASIS, patients were labeled as having major stroke if there was occlusion of distal internal carotid artery, proximal (both M1 and M2 segments) of middle cerebral artery or the basilar artery, or an Alberta Stroke Program Early CT Score ≤7. M1-BASIS differs from BASIS by classifying AIS patients with M2 occlusion as a minor stroke. We evaluated these classification systems for predicting functional outcomes (modified Rankin Scale score 0-1) at 3 months. Results-Two hundred sixty-five consecutive AIS patients treated with intravenous tissue-type plasminogen activator were included. On multivariate analysis, younger age (odds ratio, 1.039, 95% confidence interval, 1.009-1.070; P=0.011), lower National Institutes of Health Stroke Scale score (odds ratio, 1.140; 95% confidence interval, 1.073-1.210; P<0.001), and minor stroke by M1-BASIS (odds ratio, 2.376; 95% confidence interval, 1.047-5.393; P=0.039) were independent predictors of good functional outcome. When compared with National Institutes of Health Stroke Scale, the receiver operating characteristic curves for both BASIS (area under the curve, 0.721) and M1-BASIS (area under the curve, 0.795) correlated well with clinical severity scores. M1-BASIS has an additive effect with the National Institutes of Health Stroke Scale score to predict good outcomes. Conclusions-The purely radiological M1-BASIS correlates well with the clinical severity of stroke and can be a reliable prognostication tool in thrombolyzed AIS patients. This system might find an important place in the current era of telestroke. 
I
ntravenously administered tissue-type plasminogen activator (IV-tPA) remains the only approved thrombolytic agent in acute ischemic stroke (AIS). 1 One of the most important predictor of good outcome remains the shorter time-to-treatment initiation. 2 Symptomatic intracranial hemorrhage remains the most dreaded complication of systemic thrombolysis. Novel imaging parameters that lie upstream to clinical parameters in the pathophysiological chain may potentially allow better risk stratification and therapeutic decision making in AIS. The Alberta Stroke Program Early CT Score (ASPECTS) is one of the most widely used classification systems for early prognostication. 3, 4 This imaging classification measures the parenchyma at risk observed on the pre-tPA noncontrast computed tomographic (CT) scan of the brain. However, it has limitations similar to clinical rating methods, largely owing to the lack of information about location of the offending arterial occlusion.
Previous studies have demonstrated that proximal intracranial arterial occlusions detected by CT angiography (CTA) are independent predictors of poor outcome in AIS. 5 Modern intracranial vascular imaging by CT and MR in AIS provides excellent spatial resolution and important information about the location of arterial occlusion as well as early signs of parenchymal insult. Incorporation of such information often allows a better assessment of stroke severity and prognosis. The initial Boston Acute Stroke Imaging Scale (BASIS) is one such system that takes into account major arterial occlusion and parenchymal damage regardless of clinical severity. 6 We sought to validate the BASIS and its sister scoring system, the Middle Cerebral Artery-BASIS (M1-BASIS), on prethrombolysis scan to determine their value in predicting the functional outcome in our AIS patients treated with IV-tPA. 7 
Methods
Data for all AIS patients treated with IV-tPA were prospectively entered into a central registry at our tertiary care center. In addition to the demographic data, history of hypertension, diabetes mellitus, dyslipidemia, atrial fibrillation, smoking, and previous stroke were recorded. The National Institute of Health Stroke Scale scores were evaluated for all patients before administration of IV-tPA bolus, at 2 hours, 24 hours, and at 7 days or discharge (whichever was earlier). All AIS patients received standard dose of IV-tPA (0.9 mg/kg body weight; 10% given as a bolus and 90% as a continuous infusion >1 hour). A follow-up CT or CTA scan was performed for all patients <24 hours of thrombolysis. AIS were classified according to Trial of Org 10172 in Acute Stroke Treatment subtypes: large artery atherosclerosis, cardioembolism, small-vessel occlusion, stroke of other determined cause, and stroke of undetermined cause. 8 Symptomatic intracranial hemorrhage was defined as the presence of blood on day 2 CT scan, accompanied by an increase in National Institutes of Health Stroke Scale (NIHSS) score by ≥4 points. 9 Modified Rankin Scale score was evaluated at 90 days, and the score of 0 to 1 defined good outcome. The outcome measures included death during hospitalization, any bleeding, and symptomatic intracranial hemorrhage.
CT scans were obtained with a multidetector scanner (16-slice Philips Mx8000; Philips). Whole-brain noncontrast CT was performed: 120 kV, 170 mA, 2-second scan time, contiguous 6 mm axial slices. High-resolution brain CTA was performed with a multidetector helical scanner, and scans were obtained at a 1.3-mm slice thickness with a 1-mm interval during a bolus injection of 70 mL of contrast material. All CTA images were anonymized and reviewed digitally at the same workstation. Maximum intensity projection reconstructions of baseline CTA in 3 planes (axial, coronal, and sagittal) were independently assessed by 2 experienced readers (E.T. and L.Y.) blinded to patient clinical information, outcome, and results from other imaging modalities.
To test the performance of BASIS and M1-BASIS to predict the clinical outcome at 3 months, we classified patients as having major or minor strokes depending on whether a proximal cerebral artery was occluded on the CTA. Specifically, occlusion of distal internal carotid artery, proximal (M1 and M2 segments) of middle cerebral artery, and basilar artery defined a major stroke. We used the commonly used ASPECTS also to identify a major stroke (ASPECTS ≤7; patients not meeting these criteria were classified as minor strokes). 6 For M1-BASIS, M2 occlusions were considered as minor strokes also. Disputes in imaging abnormalities were resolved by consensus. The study was approved by the institutional ethics review board.
Statistical Procedures
We present the numeric variables as means and SDs or medians and ranges. Categorical variables are presented as percentages. Numeric predictors were tested using 2-sample t test or Mann-Whitney U test where applicable. Categorical predictors were evaluated using χ 2 test or Fisher exact test where applicable. Initially, univariable analysis of potential predictors was performed. Multivariable analyses were performed with logistic regression to identify predictors of good functional outcomes at 3 months. The principal analysis was the use of logistic regression to determine the independent predictors of a favorable outcome (modified Rankin Scale 0-1). Each of these predictors was examined in a simple logistic regression model, and a selection of those with P<0.10 was included as candidates into a multivariable logistic regression model with backward stepwise selection procedure. Predictor variables that were significant at P<0.05 were retained in the multivariable model. Associations are presented as odds ratios with corresponding 95% confidence intervals. Receiver operating characteristic (ROC) curves were computed for the imaging parameters studied. To determine if ASPECTS, BASIS, and M1-BASIS scales have an additive effect with NIHSS to predict the 3-month functional outcome, independent predictors of good outcomes (P<0.05) were weighted based on β coefficients from logistic regression and a scale was derived. Model calibration was assessed in the derivation cohort with the Hosmer-Lemeshow test (P>0.05 considered good calibration). ROC curves were used to assess the discriminating power of the new scales (NIHSS plus BASIS and NIHSS plus M1-BASIS) for good outcomes as compared with NIHSS alone. Finally, interobserver variability for assessment of the various scoring systems between the 2 observers was tested using kappa statistics. Statistical analysis was performed using SPSS version 20.
Results
A total of 348 patients received intravenous thrombolysis <4.5 hours of symptom-onset between 2008 and 2012. Of these, 265 patients who underwent CTA of intra-and extracranial vasculature before IV-tPA bolus were included in this study.
Median age was 65 years (range 33-92), and 182 patients (68.7%) were men. Hypertension was the commonest vascular risk factor in 181 patients (68.3%) followed by diabetes mellitus in 83 patients (31.4%) and atrial fibrillation in 93 patients (35.1%). Pretreatment median NIHSS score was 19 points (range 2-35) with the median onset-to-treatment time of 160 minutes (range 73-275). The commonest location of intracranial arterial occlusion was M1 middle cerebral artery occlusion in 135 (50.9%) followed by internal carotid artery occlusion in 58 (21.9%), distal middle cerebral artery (M2) occlusion in 20 (7.5%), and basilar artery occlusion in 21 (7.9%) patients. Only17 (6.4%) patients in our cohort had tandem lesions. The detailed information about the baseline characteristics is presented in Table 1 . The differences in 
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characteristics of patients classified with major strokes and minor strokes are shown in Table 2 , and the differences in good and poor outcomes in Table 3 . A good functional outcome was achieved by 107 (40.4%) patients. Intracranial hemorrhagic complications were observed in 65 (24.5%) patients of which 28 (10.6%) were symptomatic intracranial hemorrhage. The 3-month mortality in our study cohort was 11.7%. On univariate analysis, younger age, female sex, presence of diabetes mellitus, hypertension, smoking, atrial fibrillation, systolic blood pressure pretreatment, lower NIHSS score, minor stroke on BASIS and M1-BASIS, and ASPECTS ≥7 were significantly associated with good outcome (modified Rankin Scale 0-1) at 3 months (Table 3 ). Multivariate analysis revealed younger age (odds ratio, 1.039 per year; 95% confidence interval, 1.009-1.070; P=0.011), NIHSS score (odds ratio, 1.140 per point; 95% confidence interval, 1.073-1.210; P<0.001), and minor stroke on M1-BASIS (odds ratio, 2.376; 95% confidence interval, 1.047-5.393; P=0.039) as independently associated with good functional outcomes. The characteristics of patients classified with major stroke for ASPECTS, BASIS, and M1-BASIS are included in Table I in the onlineonly Data Supplement, and post-treatment CTA classification for major and minor strokes according to M1-BASIS in Table  II in the online-only Data Supplement.
We performed ROC curves comparing various imaging systems (BASIS, M1-BASIS, and ASPECTS) to clinical parameters (NIHSS) and found good correlation between them. The area under the curve for BASIS was 0.721, whereas that for M1-BASIS was 0.795 ( Figure 1A and 1B) . For ASPECTS, the area under the curve was 0.73 (not shown). There was fair agreement by both reviewers on dichotomized ASPECTS classification (κ coefficient=0.74). There was good agreement by both reviewers on dichotomized BASIS and M1-BASIS classification (κ coefficient=0.85).
Using β coefficient-weighted scales, we created ROC curves to determine if BASIS and M1-BASIS has an additive factor with the NIHSS to prognosticate outcomes. On regression, when adding BASIS to NIHSS, the β weightage was 0.095 per point on the NIHSS score and 0.960 for the presence of major strokes on BASIS with a constant of −2.251. When adding M1-BASIS to NIHSS, β weightage was 0.096 per point on the NIHSS score and 1.013 for the presence of major stroke on M1-BASIS with a constant of −2.224. Our results show that the area under the curve for NIHSS alone was 0.728 to predict good outcomes, whereas that of NIHSS plus BASIS was 0.736; the 2 ROC curves were not significantly different (Figure 2A ). The area under the curve for NIHSS plus M1-BASIS was improved to 0.779, which was statistically significant (z=−0.1676; P=0.047) when compared with the purely NIHSS ROC ( Figure 2B ). This shows that M1-BASIS does have an additive effect with the NIHSS to prognosticate 3-month outcomes. 
Discussion
Our study shows that the simple and rapidly administered CTA-based scoring systems are reliable in predicting the functional outcome in IV-tPA-treated AIS patients at 3 months.
Several clinical instruments have been used for the assessment and prognostication of AIS patients. [10] [11] [12] Although they are widely used, most of them have inherent deficiencies. 13, 14 NIHSS is the most widely used clinical rating instrument for AIS. 15 However, it is purely a clinical scale and does not take into account radiological features and may over-or underestimate stroke severity in some cases. Supplementing the findings on MR imaging, sonography, and CTA data to NIHSS 
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score is known to improve the predictive power of the latter. [16] [17] [18] [19] For example, a patient with proximal internal carotid artery or middle cerebral artery occlusion may present with a very low NIHSS score, which may deem the patient ineligible for systemic thrombolysis. Some of these patients may present with minor symptoms, largely because of the recruitment of early collaterals that may fail later and lead to delayed deterioration. 20 This phenomenon may be prevented by obtaining vascular information from imaging-based classification systems such as BASIS and M1-BASIS.
Stroke classification instruments based on imaging alone have been proposed. [21] [22] [23] [24] Smith et al 5 demonstrated the value of identifying a proximal intracranial artery occlusion by CTA in predicting poor neurological outcome in AIS. They reported that a combination of baseline NIHSS score and the presence of intracranial arterial may allow for more accurate prognostication.
A scoring system for AIS must be simple, rapid, reproducible, and possible in a variety of clinical settings. Detailed clinical rating instruments are commonly used in the settings of a clinical trial to demonstrate the efficacy of a new treatment. 15 However, in AIS where the speed of treatment initiation is important, the treating physician may not always have the luxury of performing a detailed examination. Perhaps, some concrete radiological parameters may help in expediting the therapeutic decision making. With expanding telemedicine-assisted stroke thrombolysis services, there is an increasing impetus to find simple and reliable radiological imaging characteristics to facilitate treatment initiation at a peripheral location. BASIS and M1-BASIS take into account the presence of a large artery occlusion, which can be easily identified on the CTA. Accordingly, BASIS and M1-BASIS have been found to be effective in predicting poor outcomes in stroke patients and were independent of the modality used, whether CT or MRI. An advantage of BASIS and M1-BASIS compared with ASPECTS is their applicability to both anterior and posterior circulation strokes. BASIS was also found to be significantly superior to ASPECTS in identifying patients who have a high probability of poor outcomes despite a lack of significant parenchymal abnormalities on noncontrast CT scan. 21 The sensitivity of BASIS was 91.7% with a specificity of 30.1% to predict modified Rankin Scale of 0 to 1 at 3 months, whereas the sensitivity of M1-BASIS was 88.7% with a specificity of 48.7%. This is expected because not all patients experience recanalization, and a small infarct in a critical location can cause a large deficit.
Our study demonstrates that ASPECTS, BASIS, and M1-BASIS closely approximated the clinical severity of stroke (NIHSS score) in AIS patients treated with IV-tPA as shown by the ROC curves (Figure 1 ). This translated into the ability to prognosticate patient outcomes at 3 months purely based on these radiological parameters. Although minor strokes on ASPECTS and BASIS showed a trend toward favorable functional outcomes, only minor strokes by M1-BASIS were able to achieve favorable outcomes at 3 months. Importantly, we have also shown how M1-BASIS can add a significant advantage in prognosticating a patient's 3-month outcome when added to the clinical assessment.
Our study is limited by the retrospective design and a moderate sample size. Our cohort's higher median NIHSS (19 points), with more radiologically evident larger strokes, could have accounted for a better applicability of the imaging-based scoring system. Our population had a relatively higher proportion of cardioembolic strokes, probably responsible for the higher prevalence of proximal intracranial arterial occlusions, higher NIHSS scores, and larger parenchymal ischemic signs.
In conclusion, M1-BASIS correlates well with the clinical severity of stroke and can reliably prognosticate outcome in AIS patients treated with systemic thrombolysis. Perhaps, larger and prospective studies are needed to establish this association and develop it as a rapid assessment tool in AIS.
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